Symposiums

Darolutamide in combination with androgen deprivation therapy (ADT) is approved by the FDA for the treatment of metastatic hormone-sensitive…

Outdoor athletes and active individuals have frequent and prolonged UV exposure and are at increased risk of skin cancer.1-3 Athletes are…

Two leading experts discuss the COVID-19 post-exposure prevention gap, especially in high-contact and group care settings among vulnerable…

A large portion of the session focused on what the guidelines referred to as the “indeterminate phase” or “grey zone” of CHB, a term…

New evidence challenges traditional COPD management, suggesting that earlier intervention may improve outcomes and reduce exacerbation…

The therapeutic landscape in non-muscle-invasive bladder cancer (NMIBC) is advancing with the investigation of new treatment…

Treatment of early breast cancer (eBC) is continuing to advance, and pivotal Phase III trial data released at the San Antonio Breast…

Experts examine the clinical evidence for JAK inhibitors in long-term management of alopecia areata…